Search
for
Sort by
Research 211–240 of 478
- Pro-inflammatory Vδ1+T-cells infiltrates are present in and around the hair bulbs of non-lesional and lesional alopecia areata hair follicles
- Involvement of ILC1-like innate lymphocytes in human autoimmunity, lessons from alopecia areata
- RETRACTED: Causal role of immune cells in alopecia areata: A two‐sample Mendelian randomization study
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- Hair follicles as immune targets: unraveling cellular players, cytokine crosstalk, and precision pathways for future therapy of alopecia areata
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- 001 Human scalp hair follicles are protected from alopecia areata in vivo by regulatory γδT cells
- 185 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Overview of Alopecia Areata
- JAK Inhibitors for Treatment of Alopecia Areata
- Hair regrowth in alopecia areata patients following Stem Cell Educator therapy
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Blocking Potassium Channels (Kv1.3): A New Treatment Option for Alopecia Areata?
- Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss